Latest News and Press Releases

Dharma will license the Company’s proprietary technology platform “Sail” to use at the point of care within Dharma dispensaries and its network of support centers in Virginia.Sail will be used to...

TORONTO, July 08, 2020 (GLOBE NEWSWIRE) -- CB2 Insights Inc. (“CB2” or the “Company”) (CSE: CBII; OTCQB: CBIIF), will be hosting its Q1 2020 earnings call on Wednesday, July 15, 2020 at 9:00 a.m....

TORONTO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“CB2” or the “Company”), a leading technology company focused on mainstreaming medical cannabis to the healthcare...

TORONTO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII; OTCQB:CBIIF), a leading data-driven company focused on bringing real-world evidence driven from the...

TORONTO, July 31, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...

NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21Project TWENTY21 aims to enroll 20,000 patients...

NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21Project TWENTY21 aims to enroll 20,000 patients...

TORONTO, June 24, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...

TORONTO, April 30, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBTOF) (“CB2” or the “Company”), a leading data-analytics company focused on bringing real-world evidence driven from the...